Greater Cannabis Company (GCAN) Net Cash Flow (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Net Cash Flow of $624.0 in Q1 2026, up 102.58% quarter-over-quarter from -$24140.0 in Q4 2025, and up 105.59% on a YoY basis from $303.51 in Q1 2025.
Greater Cannabis Company (GCAN) Net Cash Flow (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Net Cash Flow history runs 10 years deep, the most recent figure standing at $624.0 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 105.59% year-over-year to $624.0; the TTM figure through Mar 2026 stood at -$48374.0 (up 41.8% YoY), while the FY2025 annual figure was -$56553.0, up 48.35% from the prior year.
- Net Cash Flow was $624.0 for Q1 2026 at Greater Cannabis Company, up from -$24140.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $624.0 in Q1 2026 to a low of -$56392.0 in Q2 2022.
- Historically, Net Cash Flow has averaged -$22334.2 across 5 years, with a median of -$19064.0 in 2022.
- The sharpest annual moves came in 2025 and 2026: Net Cash Flow plunged 391.25% in 2025, then jumped 105.59% in 2026.
- A 5-year view of Net Cash Flow shows it stood at -$19064.0 in 2022, then tumbled by 71.39% to -$32673.0 in 2023, then surged by 84.96% to -$4914.0 in 2024, then tumbled by 391.25% to -$24140.0 in 2025, then soared by 102.58% to $624.0 in 2026.
- The last three Net Cash Flow figures came in at $624.0 (Q1 2026), -$24140.0 (Q4 2025), and -$5357.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | Greater Cannabis Company | - | - | - | 624.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 624.00 |
| Mar 31, 2026 | 624.00 |
| Dec 31, 2025 | -24,140.00 |
| Dec 31, 2025 | -24,140.00 |
| Sep 30, 2025 | -5,357.00 |
| Sep 30, 2025 | -5,357.00 |
| Jun 30, 2025 | -19,501.00 |
| Jun 30, 2025 | -19,501.00 |
| Mar 31, 2025 | -11,155.00 |
| Mar 31, 2025 | -11,155.00 |
| Dec 31, 2024 | -4,914.00 |
| Dec 31, 2024 | -4,914.00 |
| Sep 30, 2024 | -18,034.00 |
| Sep 30, 2024 | -18,034.00 |
| Jun 30, 2024 | -49,007.00 |
| Jun 30, 2024 | -49,007.00 |
| Mar 31, 2024 | -37,536.00 |
| Mar 31, 2024 | -37,536.00 |
| Dec 31, 2023 | -32,673.00 |
| Dec 31, 2023 | -32,673.00 |